In Episode 167 of Money Matters USA, David Esposito, President and CEO of ONL Therapeutics, shares insights from his military background and how it shaped his leadership style. He discusses the dynamics of working in small biotech companies versus large corporations, the challenges of treating retinal diseases, and the importance of AI in early detection. David also delves into the FDA approval process and the innovative approaches ONL Therapeutics is taking to improve patient outcomes.

Reach Fred at 800-593-8188.

Money Matters USA

https://harvesttimepartners.com

https://onltherapeutics.com

See omnystudio.com/listener for privacy information.